Huaier granule for proteinuria in breast cancer patients
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether Huaier Granule, a traditional Chinese medicine, can help reduce protein in the urine (proteinuria) in people with breast cancer who are undergoing or have had immunotherapy. The goal is to see if this treatment can protect your kidneys and improve your quality of life during cancer therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman between 18 and 75 years old.
- You have a confirmed breast cancer diagnosis.
- You are currently on or have previously had immunotherapy or anti-angiogenic treatment.
- Your urine test shows protein for the first time, with a specific amount between 0.15g and 3.5g per day.
- You are generally in good health, able to care for yourself, and expected to live at least 6 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Huaier granules, a Chinese herbal medicine, can reduce protein in the urine caused by bevacizumab or anlotinib treatment for lung cancer. If you're experiencing this side effect, the trial may help manage it.
This study tests whether a traditional Chinese herbal medicine called Huaier granules can help lower tumor marker levels in the blood of people who have been treated for breast cancer. Tumor markers are substances that can indicate whether cancer is present or active; lowering them may be a sign that the cancer is under control.
This trial tests whether Huaier granules, a traditional Chinese medicine, can help people with advanced breast cancer that has not spread to major organs like the liver or lungs. You may join if you've had no more than one prior treatment and your cancer is not curable with surgery or radiation.
This trial looks at whether adding Huaier granules to usual after-surgery treatment can improve outcomes for people with high-risk early-stage triple-negative breast cancer. It focuses on whether the added supplement is safe and helpful after standard care.
This trial tests whether a Chinese herbal medicine called Huaier granules works better than standard chemotherapy for people with pancreatic cancer that was removed by surgery. Participants can choose to take Huaier granules or standard chemotherapy, and researchers will compare outcomes.
This study tests whether Huaier granules can help prevent lung cancer from coming back after surgery. It is for people with stage II–IIIA non-small cell lung cancer who have recently had their tumor completely removed and have not had other treatments like chemotherapy or radiation.
Hear when a new Proteinuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.